<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">morpho</journal-id><journal-title-group><journal-title xml:lang="ru">Морфологические ведомости</journal-title><trans-title-group xml:lang="en"><trans-title>Morphological newsletter</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1812-3171</issn><issn pub-type="epub">2686-8741</issn><publisher><publisher-name>Private Medical University REAVIZ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20340/mv-mn.2020.28(2):64-73</article-id><article-id custom-type="elpub" pub-id-type="custom">morpho-420</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>МОРФОЛОГИЯ ЛЕГКИХ ПРИ ЭКСПЕРИМЕНТАЛЬНОМ ОСТРОМ ПОВРЕЖДЕНИИ И ЕГО ФАРМАКОКОРРЕКЦИИ</article-title><trans-title-group xml:lang="en"><trans-title>THE MORPHOLOGY OF THE LUNGS AT THE EXPERIMENTAL ACUTE INJURY AND ITS PHARMACOCORRECTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>Олег Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>Oleg A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры фармакологии и клинической фармакологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">oleg-kulikov-84@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балашов</surname><given-names>Владимир Павлович</given-names></name><name name-style="western" xml:lang="en"><surname>Balashov</surname><given-names>Vladimir P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор биологических наук, профессор, заведующий кафедрой цитологии, гистологии и эмбриологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">bvp63@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеев</surname><given-names>Валентин Павлович</given-names></name><name name-style="western" xml:lang="en"><surname>Ageev</surname><given-names>Valentin P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры химии и технологии физиологически активных веществ Института физики и химии</p></bio><bio xml:lang="en"/><email xlink:type="simple">valeageev@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>Елена Васильевна</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>Elena V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры фармакологии и клинической фармакологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">yelenadan@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шляпкина</surname><given-names>Василиса Игоревна</given-names></name><name name-style="western" xml:lang="en"><surname>Shlyapkina</surname><given-names>Vasilisa I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка 4 курса специальности «фармация»</p></bio><bio xml:lang="en"/><email xlink:type="simple">shlyapkina.98@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Замышляев</surname><given-names>Павел Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Zamyshlyaev</surname><given-names>Pavel S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры анестезиологии и реаниматологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">zamyshlyaev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ломачкина</surname><given-names>Марина Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Lomachkina</surname><given-names>Marina S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор кафедры анестезиологии и реаниматологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">ms.lomachkina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Летин</surname><given-names>Александр Владиславович</given-names></name><name name-style="western" xml:lang="en"><surname>Letin</surname><given-names>Aleksandr V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студент 6 курса специальности «лечебное дело»</p></bio><bio xml:lang="en"/><email xlink:type="simple">alexander.letin@icloud.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный исследовательский Мордовский государственный университет имени Н.П. Огарева, Саранск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ogarev National Research Mordovian State University, Saransk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>20</day><month>08</month><year>2020</year></pub-date><volume>28</volume><issue>2</issue><fpage>64</fpage><lpage>73</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Куликов О.А., Балашов В.П., Агеев В.П., Семенова Е.В., Шляпкина В.И., Замышляев П.С., Ломачкина М.С., Летин А.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Куликов О.А., Балашов В.П., Агеев В.П., Семенова Е.В., Шляпкина В.И., Замышляев П.С., Ломачкина М.С., Летин А.В.</copyright-holder><copyright-holder xml:lang="en">Kulikov O.A., Balashov V.P., Ageev V.P., Semenova E.V., Shlyapkina V.I., Zamyshlyaev P.S., Lomachkina M.S., Letin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.morpholetter.com/jour/article/view/420">https://www.morpholetter.com/jour/article/view/420</self-uri><abstract><p>Изучение морфологии легких при влиянии различных факторов внешней среды представляет большой интерес для различных направлений медицины и биологии. В работе проведено исследование патоморфологических изменений респираторного отдела легкого крыс при аспирационном остром повреждении и действии фармакокоррекции. В качестве повреждающего агента был использован ацетон, в качестве средств фармакокоррекции – препарат ГиперХАЕС, содержащий 7,2% раствор NaCl в сочетании с 6% гидроксиэтилкрахмала, а также липосомальную форму N-ацетилцистеина, которые вводили подопытным животным внутривенно однократно после индуцирования острого повреждения легких. Контрольная группа животных получала антибиотикотерапию. Окраску микропрепаратов осуществляли с помощью гематоксилина и эозина. Проводили количественную оценку гистологических признаков повреждения тканей легких. В результате исследования макропрепаратов легких была установлена степень легочного отека, а также противоотечное действие средств фармакокоррекции. На 6-е сутки эксперимента противоотечное действие сохранялось только после введения N-ацетилцистеина. Гистологическое исследование легких показало генерализованную деструкцию архитектоники органа в ответ на воздействие повреждающего фактора и ее редукцию под влиянием средств фармакокоррекции. В контрольной группе, признаки острого повреждения легких были наиболее обширными. Спустя сутки после введения раствора ГиперХАЕС в гистологической картине легких отсутствовали кровоизлияния. При количественной оценке гистологических признаков острого повреждения легких показано, что максимальный положительный эффект от введения ГиперХАЕС развивается через 24 часа после применения. N-ацетилцистеин в первую очередь приводил к уменьшению лейкоцитарной инфильтрации и препятствовал развитию нагноительного процесса. Пульмо-протективное действие N-ацетилцистеина реализовывалось через 24 часа от момента введения и сохранялось до 6-х суток эксперимента. Использование при остром повреждении легких средств фармакологической коррекции отражалось на картине летальности подопытных животных. При применении ГиперХАЕС к 6 дню погибло 37,5% животных, в группе с N-ацетилцистеином – 28,6%, тогда как в контрольной группе все животные погибли.</p></abstract><trans-abstract xml:lang="en"><p>The study of lung morphology under the influence of various environmental factors is of great interest for various areas of medicine and biology. The study of pathological changes in the respiratory part of the lung of rats with aspiration acute injury and the action of pharmacological correction was carried out. Acetone was used as a damaging agent, and HyperHAES was used as a means of pharmacological correction, containing 7.2% NaCl solution in combination with 6% hydroxyethyl starch, as well as a liposomal form of N-acetylcysteine, which was administered to experimental animals once intravenously after induction of acute lung injury. The control group of animals received antibiotic therapy. The staining of the slides was carried out using hematoxylin and eosin. A quantitative assessment of the histological signs of lung tissue damage was carried out. As a result of the study of preparations of the lungs, the degree of pulmonary edema was established, as well as the anti-edema effect of pharmacological corrections. On the 6th day of the experiment, the anti-edematous effect was retained only after the introduction of N-acetylcysteine. Histological examination of the lungs showed generalized destruction of the organ architectonics in response to the impact of a damaging factor and its reduction under the influence of pharmacological corrections. In the control group, the signs of acute lung injury were most extensive. One day after the administration of the HyperHAEC solution, there were no hemorrhages in the histological picture of the lungs. In a quantitative assessment of the histological signs of acute lung injury, it was shown that the maximum positive effect from the administration of HyperHAES develops 24 hours after application. N-acetylcysteine primarily led to a decrease in leukocyte infiltration and prevented the development of a suppurative process. The lung-protective effect of N-acetylcysteine was realized in 24 hours from the moment of administration and persisted until the 6th day of the experiment. The use of pharmacological correction agents in acute lung injury was reflected in the picture of the lethality of the experimental animals. When HyperHAES was applied, 37.5% of animals died by day 6, in the group with N-acetylcysteine - 28.6%, while in the control group all animals died.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острое повреждение легких</kwd><kwd>патоморфология легкого</kwd><kwd>ацетон</kwd><kwd>N-ацетилцистеин</kwd><kwd>ГиперХАЕС</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute lung injury</kwd><kwd>lung pathology</kwd><kwd>acetone</kwd><kwd>N-acetylcysteine</kwd><kwd>HyperHAES</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Novikov NY. Vliyanie gemodinamicheskogo i membranogennogo faktorov oteka na morfologicheskie izmeneniya v legkikh. Zaporozhskiy meditsinskiy zhurnal. 2012;71(2):41–42.</mixed-citation><mixed-citation xml:lang="en">Novikov NY. Vliyanie gemodinamicheskogo i membranogennogo faktorov oteka na morfologicheskie izmeneniya v legkikh. Zaporozhskiy meditsinskiy zhurnal. 2012;71(2):41–42.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shaman. Premradzh Sudebno-meditsinskaya otsenka dinamiki morfologicheskikh izmeneniy dykhatel'noy sistemy pri aspiratsii zheludochnogo soderzhimogo i krovi. Avtoreferat diss. kand. med. nauk: 14.03.05. Moskva, 2011. S. 22.</mixed-citation><mixed-citation xml:lang="en">Shaman. Premradzh Sudebno-meditsinskaya otsenka dinamiki morfologicheskikh izmeneniy dykhatel'noy sistemy pri aspiratsii zheludochnogo soderzhimogo i krovi. Avtoreferat diss. kand. med. nauk: 14.03.05. Moskva, 2011. S. 22.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chow CW, Herrera MT, Suzuki T, Downey GP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003;29(4):427–431. DOI:10.1165/rcmb.F278.</mixed-citation><mixed-citation xml:lang="en">Chow CW, Herrera MT, Suzuki T, Downey GP. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003;29(4):427–431. DOI:10.1165/rcmb.F278.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shuvaev VV, Han J, Tliba S, Arguiri E, Christofidou-Solomidou M, Ramirez SH, Dykstra H, Persidsky Y, Atochin DN, Huang PL, Muzykantov VR. Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo. PLoS ONE. 2013;(8)10:e77002. DOI: 10.1371/journal.pone.0077002.</mixed-citation><mixed-citation xml:lang="en">Shuvaev VV, Han J, Tliba S, Arguiri E, Christofidou-Solomidou M, Ramirez SH, Dykstra H, Persidsky Y, Atochin DN, Huang PL, Muzykantov VR. Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo. PLoS ONE. 2013;(8)10:e77002. DOI: 10.1371/journal.pone.0077002.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gorąca A, Józefowicz-Okonkwo G. Protective effect of an early treatment with lipoic acid in LPS-induced lung injury in rats. J Physiol Pharmacol. 2007;58(3):541–549.</mixed-citation><mixed-citation xml:lang="en">Gorąca A, Józefowicz-Okonkwo G. Protective effect of an early treatment with lipoic acid in LPS-induced lung injury in rats. J Physiol Pharmacol. 2007;58(3):541–549.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013;41(2):472–480. DOI:10.1097/CCM.0b013e31826ab377</mixed-citation><mixed-citation xml:lang="en">Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013;41(2):472–480. DOI:10.1097/CCM.0b013e31826ab377</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zafar MA, Hussain MH, Muhammad G, Saqib M. Potential Use of Hypertonic Saline Solution (7-7.5% NaCl) Resuscitation in Hypovolemic and Endotoxic Shock. International journal of agriculture and biology. 2004;6(5):926–930.</mixed-citation><mixed-citation xml:lang="en">Zafar MA, Hussain MH, Muhammad G, Saqib M. Potential Use of Hypertonic Saline Solution (7-7.5% NaCl) Resuscitation in Hypovolemic and Endotoxic Shock. International journal of agriculture and biology. 2004;6(5):926–930.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yu G, Chi X, Hei Z, Shen N, Chen J, Zhang W, Li S. Small volume resuscitation with 7.5% hypertonic saline, hydroxyethyl starch 130/0.4 solution and hypertonic sodium chloride hydroxyethyl starch 40 injection reduced lung injury in endotoxin shock rats: Comparison with saline. Pulmonary Pharmacology &amp; Therapeutics. 2012;25(1):27–32. DOI:10.1016/j.pupt.2011.10.003.</mixed-citation><mixed-citation xml:lang="en">Yu G, Chi X, Hei Z, Shen N, Chen J, Zhang W, Li S. Small volume resuscitation with 7.5% hypertonic saline, hydroxyethyl starch 130/0.4 solution and hypertonic sodium chloride hydroxyethyl starch 40 injection reduced lung injury in endotoxin shock rats: Comparison with saline. Pulmonary Pharmacology &amp; Therapeutics. 2012;25(1):27–32. DOI:10.1016/j.pupt.2011.10.003.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Roch A, Hraiech S, Dizier S, Papazian L. Pharmacological interventions in acute respiratory distress syndrome. Annals of Intensive Care. 2013;3(20):1–9. DOI:10.1186/2110-5820-3-20.</mixed-citation><mixed-citation xml:lang="en">Roch A, Hraiech S, Dizier S, Papazian L. Pharmacological interventions in acute respiratory distress syndrome. Annals of Intensive Care. 2013;3(20):1–9. DOI:10.1186/2110-5820-3-20.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, Brasel KJ, Tisherman SA, Coimbra R, Rizoli S, Minei JP, Hata JS, Sopko G, Evans DC, Hoyt DB. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011;253(3):431–441. DOI:10.1097/SLA.0b013e3181fcdb22.</mixed-citation><mixed-citation xml:lang="en">Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, Brasel KJ, Tisherman SA, Coimbra R, Rizoli S, Minei JP, Hata JS, Sopko G, Evans DC, Hoyt DB. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011;253(3):431–441. DOI:10.1097/SLA.0b013e3181fcdb22.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mitsopoulos P, Suntres ZE. Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression. Journal of Toxicology. 2011;2011:1–14. DOI:10.1155/2011/808967.</mixed-citation><mixed-citation xml:lang="en">Mitsopoulos P, Suntres ZE. Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression. Journal of Toxicology. 2011;2011:1–14. DOI:10.1155/2011/808967.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Morecroft I, White K, Caruso P, Nilsen M, Loughlin L, Alba R, Reynolds PN, Danilov SM, Baker AH, Maclean MR. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension. Mol Ther. 2012;20(8):1516–1528. DOI:10.1038/mt.2012.70.</mixed-citation><mixed-citation xml:lang="en">Morecroft I, White K, Caruso P, Nilsen M, Loughlin L, Alba R, Reynolds PN, Danilov SM, Baker AH, Maclean MR. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension. Mol Ther. 2012;20(8):1516–1528. DOI:10.1038/mt.2012.70.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kulikov OA, Ageev VP, Marochkina EE, Dolgacheva IS, Minayeva OV, Inchina VI. Efficacy of liposomal dosage forms and hyperosmolar salines in experimental pharmacotherapy of acute lung injury. Research Results in Pharmacology. 2019;5(2):23–41. DOI 10.3897/rrpharmacology.5.35529.</mixed-citation><mixed-citation xml:lang="en">Kulikov OA, Ageev VP, Marochkina EE, Dolgacheva IS, Minayeva OV, Inchina VI. Efficacy of liposomal dosage forms and hyperosmolar salines in experimental pharmacotherapy of acute lung injury. Research Results in Pharmacology. 2019;5(2):23–41. DOI 10.3897/rrpharmacology.5.35529.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kulikov OA, Inchina VI, Semenova EV, Semenov AV. Sposob modelirovaniya i farmakologicheskoy korrektsii sindroma ostrogo povrezhdeniya legkikh v eksperimente. Patent na izobretenie. № 2541831. 2015. https://patentinform.ru/inventions/reg-2541831.html.</mixed-citation><mixed-citation xml:lang="en">Kulikov OA, Inchina VI, Semenova EV, Semenov AV. Sposob modelirovaniya i farmakologicheskoy korrektsii sindroma ostrogo povrezhdeniya legkikh v eksperimente. Patent na izobretenie. № 2541831. 2015. https://patentinform.ru/inventions/reg-2541831.html.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Galvão AM, Galvão JS, Pereira MA, Cadena PG, Magalhães NS, Fink JB, de Andrade AD, Castro CM, de Sousa Maia MB. Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis. Respiratory Physiology &amp; Neurobiology. 2016;231:55–62. DOI:10.1016/j.resp.2016.06.001.</mixed-citation><mixed-citation xml:lang="en">Galvão AM, Galvão JS, Pereira MA, Cadena PG, Magalhães NS, Fink JB, de Andrade AD, Castro CM, de Sousa Maia MB. Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis. Respiratory Physiology &amp; Neurobiology. 2016;231:55–62. DOI:10.1016/j.resp.2016.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fominskiy EV Ispol'zovanie rastvora 7,2% NaCl / 6% gidroksietilirovannogo krakhmala 200/0,5 pri operatsiyakh revaskulyarizatsii miokarda v usloviyakh iskusstvennogo krovoobrashcheniya. Diss. kand. med. nauk: 14.01.20. Novosibirsk, 2013. 125s.</mixed-citation><mixed-citation xml:lang="en">Fominskiy EV Ispol'zovanie rastvora 7,2% NaCl / 6% gidroksietilirovannogo krakhmala 200/0,5 pri operatsiyakh revaskulyarizatsii miokarda v usloviyakh iskusstvennogo krovoobrashcheniya. Diss. kand. med. nauk: 14.01.20. Novosibirsk, 2013. 125s.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gushchin YI, Muzhikyan AA Vliyanie razlichnykh metodov evtanazii na gistologicheskuyu kartinu legkikh melkikh laboratornykh zhivotnykh. Mezhdunarodnyy vestnik veterinarii. 2014;(4):96-104. DOI:10.29296/2618723X-2018-03-05.</mixed-citation><mixed-citation xml:lang="en">Gushchin YI, Muzhikyan AA Vliyanie razlichnykh metodov evtanazii na gistologicheskuyu kartinu legkikh melkikh laboratornykh zhivotnykh. Mezhdunarodnyy vestnik veterinarii. 2014;(4):96-104. DOI:10.29296/2618723X-2018-03-05.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Torkunov PA. Farmakologicheskaya korrektsiya toksicheskogo oteka legkikh. Diss. d-ra. med. nauk. SPb, 2007. 240s.</mixed-citation><mixed-citation xml:lang="en">Torkunov PA. Farmakologicheskaya korrektsiya toksicheskogo oteka legkikh. Diss. d-ra. med. nauk. SPb, 2007. 240s.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shen W, Gan J, Xu S, Jiang G, Wu H. Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Pharmacol. Res. 2009;60(4):296–302. DOI:10.1016/j.phrs.2009.04.007.</mixed-citation><mixed-citation xml:lang="en">Shen W, Gan J, Xu S, Jiang G, Wu H. Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Pharmacol. Res. 2009;60(4):296–302. DOI:10.1016/j.phrs.2009.04.007.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Holms CA, Otsuki DA, Kahvegian M, Massoco CO, Fantoni DT, Gutierrez PS, Auler Junior JO. Effect of hypertonic saline treatment on the inflammatory response after hydrochloric acid-induced lung injury in pig. Clinics. 2015;70(8):577–583. DOI:10.6061/clinics/2015(08)08.</mixed-citation><mixed-citation xml:lang="en">Holms CA, Otsuki DA, Kahvegian M, Massoco CO, Fantoni DT, Gutierrez PS, Auler Junior JO. Effect of hypertonic saline treatment on the inflammatory response after hydrochloric acid-induced lung injury in pig. Clinics. 2015;70(8):577–583. DOI:10.6061/clinics/2015(08)08.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
